ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESR35

The control of sporulation and antibiotic production through c-di-GMP signaling

Active
Institution
Cornell University, NY
Principal investigator
Kelley Ann Gallagher
Funding
$384K
Duration
2025–2029
Open portfolio

Moonbase score

Still being scored

Abstract

PROJECT SUMMARY In all domains of life, cells must employ tightly controlled mechanisms to regulate global processes in response to environmental inputs. In bacteria, signaling through the nucleotide second messenger 3’,5’-cyclic diguanylic acid (c-di-GMP) is one of the most conserved mechanisms cells use to trigger lifestyle changes in response to specific environmental cues. Although the enzymes that synthesize and degrade c-di-GMP can be found in all bacterial phyla, studies of this second messenger have focused on model species belonging to the Phylum Pseudomonadota. A key knowledge gap is understanding how this fundamental mechanism governs regulation of gene expression in diverse bacterial phyla. This project will address this by characterizing the molecular mechanisms and evolution of c-di-GMP signaling in the antibiotic-producing bacterial genus Streptomyces, which belongs to Phylum Actinobacteria (synonym Actinomycetota). In Streptomyces, c-di-GMP is the central integrator controlling a highly unusual life cycle that involves progression from vegetative growth to production of reproductive aerial hyphae that differentiate into chains of spores. To investigate the molecular basis and functional diversification of c-di-GMP signaling, this project will focus on three areas: (1) the mechanisms through which c-di-GMP regulates progression through the developmental life cycle in the model species Streptomyces venezuelae; (2) the evolution and distribution of conserved components of c-di-GMP signaling networks; and (3) the impact of c-di-GMP on antibiotic biosynthesis, which is tightly controlled along with the developmental life cycle, in diverse antibiotic-producing actinobacterial species. These studies will contribute to a fundamental understanding of how bacterial control gene expression and will leverage this knowledge to manipulate antibiotic production.

LOADING MOONBASE SCORE

R35NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESSpecial Emphasis Panel[ZRG1 MGG-F (55)]messengerbacterialsignalingantibiotictightly controlledtightlylife cyclesignaling project

Questions for Cornell University

Answered by the team behind this research.

Same institution, same topic, scored first.